The presence and progression of choroidal neurofibromas in a predominantly pediatric population with neurofibromatosis type-1

References

• Gutmann DH, Wood DL, Collins FS. Identification of the neurofibromatosis type 1 gene product. Proc Natl Acad Sci U S A. 1991;88(21):9658–62. doi:10.1073/pnas.88.21.9658. Cited in PubMed; PMID:1946382.
   PubMed Web of Science ®Google Scholar
• Mulvihill JJ, Parry DM, Sherman JL, Pikus A, Kaiser-Kupfer MI, Eldridge R. NIH conference. Neurofibromatosis 1 (Recklinghausen disease) and neurofibromatosis 2 (bilateral acoustic neurofibromatosis). An update. Ann Intern Med. 1990;113(1):39–52. doi:10.7326/0003-4819-113-1-39. Cited in PubMed; PMID:2112353.
   PubMed Web of Science ®Google Scholar
• Neurofibromatosis. Conference statement. National institutes of health consensus development conference. Arch Neurol. 1988;45(5):575–78. Cited in PubMed; PMID:3128965.
   PubMedGoogle Scholar
• Gutmann DH, Aylsworth A, Carey JC, Korf B, Marks J, Pyeritz RE, Rubenstein A, Viskochil D. The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2. JAMA. 1997;278(1):51–57. doi:10.1001/jama.1997.03550010065042. Cited in PubMed; PMID:9207339.
   PubMed Web of Science ®Google Scholar
• DeBella K, Szudek J, Friedman JM. Use of the national institutes of health criteria for diagnosis of neurofibromatosis 1 in children. Pediatrics. 2000;105(3 Pt 1):608–14. doi:10.1542/peds.105.3.608. Cited in PubMed; PMID:10699117.
   PubMed Web of Science ®Google Scholar
• Obringer AC, Meadows AT, Zackai EH. The diagnosis of neurofibromatosis-1 in the child under the age of 6 years. Am J Dis Child. 1989;143(6):717–19. doi:10.1001/archpedi.1989.02150180099028. Cited in PubMed; PMID:2499182.
   PubMedGoogle Scholar
• Ragge NK, Falk RE, Cohen WE, Murphree AL. Images of Lisch nodules across the spectrum. Eye. 1993;7(Pt 1):95–101. doi:10.1038/eye.1993.20. Cited in PubMed; PMID:8325432.
   PubMedGoogle Scholar
• Griffiths S, Thompson P, Frayling I, Upadhyaya M. Molecular diagnosis of neurofibromatosis type 1: 2 years experience. Fam Cancer. 2007;6(1):21–34. doi:10.1007/s10689-006-9001-3. Cited in PubMed; PMID:16944272.
   PubMed Web of Science ®Google Scholar
• Reimer Wolter J. Nerve fibrils in ovoid bodies: with neurofibromatosis of the choroid. Arch Ophthalmol. 1965;73(5):696–99. doi:10.1001/archopht.1965.00970030698019. American Medical Association.
   PubMedGoogle Scholar
• Wolter JR, Gonzales-Sirit R, Mankin WJ. Neurofibromatosis of the choroid. Am J Ophthalmol. 1962;54(2):217–25. doi:10.1016/0002-9394(62)93279-8. Elsevier.
   PubMed Web of Science ®Google Scholar
• Rescaldani C, Nicolini P, Fatigati G, Bottoni FG. Clinical application of digital indocyanine green angiography in choroidal neurofibromatosis. Ophthalmologica. 1998;212(2):99–104. doi:10.1159/000027287. Cited in PubMed; PMID:9486548.
   PubMed Web of Science ®Google Scholar
• Yasunari T, Shiraki K, Hattori H, Miki T. Frequency of choroidal abnormalities in neurofibromatosis type 1. Lancet. 2000;356(9234):988–92. doi:10.1016/S0140-6736(00)02716-1. Cited in PubMed; PMID:11041400.
   PubMed Web of Science ®Google Scholar
• Ueda-Consolvo T, Miyakoshi A, Ozaki H, Houki S, Hayashi A. Near-infrared fundus autofluorescence-visualized melanin in the choroidal abnormalities of neurofibromatosis type 1. Clin Ophthalmol. 2012;6:1191–94. doi:10.2147/OPTH.S35321. Cited in PubMed; PMID:22888215.
   PubMedGoogle Scholar
• Viola F, Villani E, Natacci F, Selicorni A, Melloni G, Vezzola D, Barteselli G, Mapelli C, Pirondini C, Ratiglia R. Choroidal abnormalities detected by near-infrared reflectance imaging as a new diagnostic criterion for neurofibromatosis 1. Ophthalmology. 2012;119(2):369–75. doi:10.1016/j.ophtha.2011.07.046. Cited in PubMed; PMID:21963267.
   PubMed Web of Science ®Google Scholar
• Nakakura S, Shiraki K, Yasunari T, Hayashi Y, Ataka S, Kohno T. Quantification and anatomic distribution of choroidal abnormalities in patients with type I neurofibromatosis. Graefes Arch Clin Exp Ophthalmol. 2005;243(10):980–84. doi:10.1007/s00417-005-1184-z. Cited in PubMed; PMID:15891894.
   PubMed Web of Science ®Google Scholar
• Cassiman C, Casteels I, Jacob J, Plasschaert E, Brems H, Dubron K, Keer KV, Legius E. Choroidal abnormalities in café-au-lait syndromes: a new differential diagnostic tool? Clin Genet. 2017;91(4):529–35. doi:10.1111/cge.12873. Cited in PubMed; PMID:27716896.
   PubMed Web of Science ®Google Scholar
• Moramarco A, Giustini S, Nofroni I, Mallone F, Miraglia E, Iacovino C, Calvieri S, Lambiase A. Near-infrared imaging: an in vivo, non-invasive diagnostic tool in neurofibromatosis type 1. Graefes Arch Clin Exp Ophthalmol. 2018;256(2):307–11. doi:10.1007/s00417-017-3870-z. Cited in PubMed; PMID:29290016.
   PubMed Web of Science ®Google Scholar
• Vagge A, Camicione P, Capris C, Sburlati C, Panarello S, Calevo MG, Traverso CE, Capris P. Choroidal abnormalities in neurofibromatosis type 1 detected by near-infrared reflectance imaging in paediatric population. Acta Ophthalmol. 2015;93(8):e667–71. doi:10.1111/aos.12750. Cited in PubMed; PMID:25990002.
   PubMed Web of Science ®Google Scholar
• Goktas S, Sakarya Y, Ozcimen M, Alpfidan I, Uzun M, Sakarya R, Yarbag A. Frequency of choroidal abnormalities in pediatric patients with neurofibromatosis type 1. J Pediatr Ophthalmol Strabismus. 2014;51(4):204–08. doi:10.3928/01913913-20140513-02. Cited in PubMed; PMID:24844395.
   PubMed Web of Science ®Google Scholar
• Parrozzani R, Clementi M, Frizziero L, Miglionico G, Perrini P, Cavarzeran F, Kotsafti O, Comacchio F, Trevisson E, Convento E, et al. In Vivo detection of choroidal abnormalities related to NF1: feasibility and comparison with standard NIH diagnostic criteria in pediatric patients. Invest Ophthalmol Vis Sci. 2015;56(10):6036–42. doi:10.1167/iovs.14-16053. Cited in PubMed; PMID:26393470.
   PubMed Web of Science ®Google Scholar
• New Zealand Ministry of Health. Standard operating procedures for health and disability ethics committees. In: Ministry of Health, editor. Standard operating procedures for health and disability ethics committees. Wellington, NZ: New Zealand Ministry of Health; 2014. http://www.ethics.health.govt.nz
   Google Scholar
• New Zealand Ministry of Health. National ethics advisory committee. Ethical guidelines for observational studies: observational research, audits and related activities. National Ethics Advisory Committee. New Zealand Government; 2012.
   Google Scholar
• Stats NZ [Internet]. NZ Stat [cited 2019 Nov 10]. http://nzdotstat.stats.govt.nz/wbos/Index.aspx?DataSetCode=TABLECODE7501
   Google Scholar
• Sabbagh A, Pasmant E, Imbard A, Luscan A, Soares M, Blanché H, Laurendeau I, Ferkal S, Vidaud M, Pinson S, et al. NF1 molecular characterization and neurofibromatosis type I genotype-phenotype correlation: the French experience. Hum Mutat. 2013;34(11):1510–18. doi:10.1002/humu.22392. Cited in PubMed; PMID:23913538.
   PubMed Web of Science ®Google Scholar
• Tucci A, Saletti V, Menni F, Cesaretti C, Scuvera G, Esposito S, Melloni G, Esposito S, Milani D, Cereda C, et al. The absence that makes the difference: choroidal abnormalities in Legius syndrome. J Hum Genet. 2017;62(11):1001–04. doi:10.1038/jhg.2017.78. Cited in PubMed; PMID:28747691.
   PubMed Web of Science ®Google Scholar
• Shields CL, Kancherla S, Patel J, Vijayvargiya P, Suriano MM, Kolbus E, Badami A, Sharma P, Jacobs E, Voluck M, et al. Clinical survey of 3680 iris tumors based on patient age at presentation. Ophthalmology. 2012;119(2):407–14. doi:10.1016/j.ophtha.2011.07.059. Cited in PubMed; PMID:22035581.
   PubMed Web of Science ®Google Scholar
• Carter S. Interview with a play specialist. BMJ. 2019;364:j5783. doi:10.1136/sbmj.j5783. Cited in PubMed; PMID:31055264.
   PubMedGoogle Scholar
• de Blank PMK, Fisher MJ, Liu GT, Gutmann DH, Listernick R, Ferner RE, Avery RA. Optic pathway gliomas in neurofibromatosis Type 1: an update: surveillance, treatment indications, and biomarkers of vision. J Neuroophthalmol. 2017;37(Suppl 1):S23–32. doi:10.1097/WNO.0000000000000550. Cited in PubMed; PMID:28806346.
   PubMedGoogle Scholar
• Bilgin B, Karadag AS. Choroidal thickness in keratoconus. Int Ophthalmol. 2020;40(1):135–40. doi:10.1007/s10792-019-01156-y. Cited in PubMed; PMID:31432355.
   PubMed Web of Science ®Google Scholar
• Papali’i-Curtin AT, Cox R, Ma T, Woods L, Covello A, Hall RC. Keratoconus prevalence among high school students in New Zealand. Cornea. 2019;38(11):1382–89. doi:10.1097/ICO.0000000000002054. Cited in PubMed; PMID:31335534.
   PubMed Web of Science ®Google Scholar